Polycystic Ovarian Syndrome Therapy
Researchers from Health Research Institute report recent findings in polycystic ovarian syndrome therapy
Published in Obesity and Diabetes Week, August 18th, 2008
A new study, 'Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome,' is now available. According to a study from the United States, "Insulin resistance and obesity are common features of the polycystic ovary syndrome (PCOS). Weight loss and use of insulin-lowering drugs have been shown to improve both reproductive and metabolic aspects of PCOS."
"We evaluated exenatide (EX) and metformin (MET), alone and in combination (COM), on menstrual cyclicity, hormonal parameters, metabolic profiles, and inflammatory markers in overweight, insulin-resistant women with PCOS. Sixty...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- American College of Chest Physicians
Chest Journal: August news briefs - Columbia University's Mailman School of Public Health
Researchers report periodontal disease independently predicts new onset diabetes - JAMA and Archives Journals
Growth hormone treatment for HIV patients improves abdominal fat, but worsens glucose level - NIH/National Heart, Lung and Blood Institute
Sleep apnea linked to increased risk of death - Diabetes
Studies from Massachusetts General Hospital add new findings in the area of diabetes - Dr. Malcolm Goyns
Scientist Unlocks Secret to a Longer, Healthier Life - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
